Agilent Technologies, Inc. (NYSE:A) Director Sells $211,840.74 in Stock

Agilent Technologies, Inc. (NYSE:A) Director Daniel K. Podolsky sold 1,819 shares of the stock in a transaction dated Monday, March 31st. The stock was sold at an average price of $116.46, for a total transaction of $211,840.74. Following the sale, the director now owns 35,737 shares of the company’s stock, valued at $4,161,931.02. This trade represents a 4.84 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this link.

Agilent Technologies Stock Up 1.7 %

NYSE:A traded up $1.91 during mid-day trading on Wednesday, reaching $115.96. The stock had a trading volume of 1,947,367 shares, compared to its average volume of 1,775,063. The business’s 50 day moving average is $132.90 and its 200 day moving average is $136.32. Agilent Technologies, Inc. has a fifty-two week low of $112.47 and a fifty-two week high of $155.35. The stock has a market cap of $33.06 billion, a P/E ratio of 26.66, a PEG ratio of 3.28 and a beta of 1.19. The company has a debt-to-equity ratio of 0.56, a current ratio of 2.20 and a quick ratio of 1.66.

Agilent Technologies (NYSE:A) last posted its quarterly earnings data on Wednesday, February 26th. The medical research company reported $1.31 EPS for the quarter, topping analysts’ consensus estimates of $1.27 by $0.04. The business had revenue of $1.68 billion for the quarter, compared to analyst estimates of $1.67 billion. Agilent Technologies had a return on equity of 25.56% and a net margin of 19.27%. As a group, sell-side analysts predict that Agilent Technologies, Inc. will post 5.57 earnings per share for the current year.

Agilent Technologies Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 23rd. Shareholders of record on Tuesday, April 1st will be paid a dividend of $0.248 per share. The ex-dividend date is Tuesday, April 1st. This represents a $0.99 annualized dividend and a yield of 0.86%. Agilent Technologies’s dividend payout ratio is currently 22.76%.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently modified their holdings of A. Flynn Zito Capital Management LLC lifted its stake in shares of Agilent Technologies by 3.8% during the fourth quarter. Flynn Zito Capital Management LLC now owns 1,871 shares of the medical research company’s stock valued at $251,000 after acquiring an additional 69 shares during the period. IFP Advisors Inc boosted its holdings in shares of Agilent Technologies by 17.7% in the fourth quarter. IFP Advisors Inc now owns 458 shares of the medical research company’s stock valued at $62,000 after buying an additional 69 shares during the period. Tiemann Investment Advisors LLC increased its holdings in Agilent Technologies by 5.6% during the 4th quarter. Tiemann Investment Advisors LLC now owns 1,423 shares of the medical research company’s stock worth $191,000 after purchasing an additional 75 shares in the last quarter. Rothschild Investment LLC raised its position in Agilent Technologies by 19.2% in the 4th quarter. Rothschild Investment LLC now owns 491 shares of the medical research company’s stock valued at $66,000 after buying an additional 79 shares during the last quarter. Finally, Ascent Group LLC raised its holdings in shares of Agilent Technologies by 4.1% in the third quarter. Ascent Group LLC now owns 2,209 shares of the medical research company’s stock valued at $328,000 after purchasing an additional 87 shares during the last quarter.

Wall Street Analyst Weigh In

A number of equities analysts have recently weighed in on the stock. Robert W. Baird lowered their price target on shares of Agilent Technologies from $161.00 to $159.00 and set an “outperform” rating on the stock in a research note on Thursday, February 27th. Barclays raised Agilent Technologies from an “underweight” rating to an “equal weight” rating and increased their price objective for the company from $135.00 to $145.00 in a research note on Monday, February 10th. Citigroup raised their price objective on Agilent Technologies to $165.00 and gave the stock a “buy” rating in a report on Thursday, December 19th. Bank of America dropped their price target on shares of Agilent Technologies from $153.00 to $150.00 and set a “neutral” rating for the company in a research report on Friday, December 13th. Finally, StockNews.com raised Agilent Technologies from a “hold” rating to a “buy” rating in a research note on Tuesday, December 24th. Seven equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. According to data from MarketBeat, Agilent Technologies currently has an average rating of “Moderate Buy” and a consensus target price of $150.83.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.